Disregard Syndrome

I enjoyed the Opinion article on the Disregard Syndrome,1 and I can offer one additional reason why some researchers may disregard earlier literature. In the US and European patent systems, if one is aware of literature documenting research findings similar to those on which a patent application is based, the applicant seeking patent protection for a discovery is obliged to inform the patent office of the literature and its relevance. There is, however, no duty to search the literature. Thus, an

Written byDick Evans
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
I enjoyed the Opinion article on the Disregard Syndrome,1 and I can offer one additional reason why some researchers may disregard earlier literature. In the US and European patent systems, if one is aware of literature documenting research findings similar to those on which a patent application is based, the applicant seeking patent protection for a discovery is obliged to inform the patent office of the literature and its relevance. There is, however, no duty to search the literature. Thus, an inventor's ignorance may lead to broader patent claims. While these claims may be later proven invalid, this is much more difficult and expensive to do once the patent issues.
Dick Evans
Agilent Technologies, Inc.
Legal Department,
Intellectual Property Group
1601 California Avenue
Bldg. 17, M/S L5A
Palo Alto, CA 94304
1. I. Ginsburg, "The Disregard Syndrome: A menace to honest science?" The Scientist, 15[24]:51, Dec. 10, 2001.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies